<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03348267</url>
  </required_header>
  <id_info>
    <org_study_id>PROTEIN-FOOTBALL RECOVERY-UTH</org_study_id>
    <nct_id>NCT03348267</nct_id>
  </id_info>
  <brief_title>Protein Supplementation and Muscle Recovery in Football</brief_title>
  <acronym>PRO-FOOTBALL</acronym>
  <official_title>Effect of Milk Protein Supplementation on Muscle Recovery and Football-specific Performance During an In-season Microcycle With Two Matches</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Thessaly</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Thessaly</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Soccer is an intermittent sport including a high number of powerful actions such as
      accelerations, decelerations, changes of direction, jumps and impacts that incorporate a
      strong eccentric component and may therefore lead to skeletal muscle damage. Indeed, match
      activity is associated with the onset of muscle damage and an acute inflammatory response
      that result in attenuated performance for as long as 1 to 3 days. In competitive soccer
      though, multiple matches are performed within a small-time frame resulting in inadequate
      muscle recovery and reduced field performance. Supplementation with milk proteins following
      intense exercise protocols has been shown to stimulate protein synthesis and facilitate
      muscle recovery. Thus, the aim of the present investigation is to examine the effects of milk
      protein supplementation on muscle recovery and soccer-specific performance during an
      in-season microcycle with two matches performed three days apart.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a double-blind, cross over, repeated measures design 20 men soccer players will receive
      either placebo (PLA) or milk protein isolate (PRO, 80% casein-20% whey) throughout recovery
      following two matches performed three days apart. On match days, players will receive a dose
      immediately after the match (PLA vs PRO: 25g of protein) and then at 3h (PLA vs PRO: 30g of
      protein) and 6h (PLA vs PRO: 25g of protein) post-match. On each day of the remaining days,
      players will consume a single dose of PLA or PRO (20g of protein) with breakfast. All players
      will participate in regular in-season training following matches. Field activity during both
      matches and daily practices will be monitored using GPS devices. Heart rate will be
      continuously recorded during each match and training session. Blood samples will be collected
      at baseline as well as 2 hours after the first match, daily for three days after the first
      match, 2 hours after the second match and daily for 3 days after the second match.
      Performance (isokinetic strength, 20-m speed, repeated sprint ability) and muscle soreness
      will be assessed at baseline daily for 3 days after both matches. Muscle biopsies from vastus
      lateralis will be collected at baseline and one day after each match.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Actual">September 15, 2016</completion_date>
  <primary_completion_date type="Actual">June 30, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in creatine kinase in plasma</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Concentration of creatine kinase will be measured in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in uric acid in plasma</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Concentration of uric acid will be measured in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in protein carbonyls in blood</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Concentration of protein carbonyls will be measured in red blood cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in total antioxidant capacity</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Total antioxidant capacity will be measured in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in reduced glutathione in blood</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Concentration of reduced glutathione will be measured in in red blood cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in oxidized glutathione in blood</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Concentration of oxidized glutathione will be measured in red blood cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in malondialdehyde in blood</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Concentration of malondialdehyde will be measured in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in catalase activity</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Catalase activity will be measured in red blood cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in protein carbonyls in muscle</measure>
    <time_frame>At baseline, 24h post-Match 1 and 24h post-Match 2</time_frame>
    <description>Concentration of protein carbonyls will be measured in muscle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in intracellular signaling proteins in muscle</measure>
    <time_frame>At baseline, 24h post-Match 1 and 24h post-Match 2</time_frame>
    <description>Phosphorylation levels of Akt, mammalian target of rapamycin (mTOR) and p70S6K will be measure using western blotting.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in proteasome activities in muscle</measure>
    <time_frame>At baseline, 24h post-Match 1 and 24h post-Match 2</time_frame>
    <description>Chymotrypsin-like (CT-L), caspase-like (C-L) and trypsin-like (T-L) proteasome activities will be assayed with hydrolysis of the fluorogenic peptide LLVY-AMC, LLE-AMC and LSTR-AMC, respectively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in satellite cells in muscle</measure>
    <time_frame>At baseline, 24h post-Match 1 and 24h post-Match 2</time_frame>
    <description>Pax7, Myf5, MyoD and Myogenin will be measured in order to quantify quiescent, activated, proliferated-differentiated and fused satellite cells respectively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in repeated Sprint Ability</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>5 x 30 m sprints will be performed with 25 seconds rest in-between. Mean time for 5 sprints and fatigue index will be calculated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in countermovement jump</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Countermovement jump will be assessed on a contact platform</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in isokinetic strength of lower limbs</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Isokinetic strength will be assessed on an isokinetic dynamometer for both knee extensors and knee flexors at 120 and 180 degrees.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in match activity</measure>
    <time_frame>During Match 1 and Match 2</time_frame>
    <description>Match activity will be continuously recorded during both matches using GPS technology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in heart rate</measure>
    <time_frame>During Match 1 and Match 2</time_frame>
    <description>Heart rate will be continuously recorded during both matches using the Team Polar system.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in delayed onset of muscle soreness</measure>
    <time_frame>At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2</time_frame>
    <description>Muscle soreness will assessed during palpation of the muscle belly and the distal region of relaxed vastus medialis, vastus lateralis and rectus femoris following three repetitions of of a full squat. Subjects will rate their DOMS on a visual analogue scale (0-10).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>Over a 7-day period at baseline.</time_frame>
    <description>Dietary intake will be assessed using 7-day diet recalls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in white blood cell count.</measure>
    <time_frame>At baseline, immediately after Match 1, at 24h, 48h and 72h post-Match 1 as well as immediately after Match 2 and at 24h, 48h and 72h post-Match 2.</time_frame>
    <description>White blood cell count will be measured using an automatic blood analyzer.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Skeletal Muscle Damage</condition>
  <condition>Muscle Inflammation</condition>
  <condition>Muscle Recovery</condition>
  <condition>Soccer Performance</condition>
  <arm_group>
    <arm_group_label>Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>On the match day, 25g of protein consumed immediately after the match and then 30g at 3h (+3h) and 25g at 6h (+6h). On each day of the remaining days, 20 g of protein consumed with breakfast.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>On the match day, 500 ml received received orally immediately post-match and then at +3h and +6h. On the remaining days, 500 ml daily with breakfast.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Milk protein isolate</intervention_name>
    <description>Milk protein isolate in a powder form consisted of 80% casein and 20% whey protein. 20g were diluted into 500 ml water</description>
    <arm_group_label>Protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>500 mL drink that contained water (375 mL), sugar-free cordial (125 mL) and 2 g of low-calorie glucose/dextrose powder.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  i) participation at elite level (top three division leagues) of soccer competition for
             at least five years, ii) abstain from consumption of performance-enhancing
             supplements, antioxidant supplements and medications (for at least 6 months before and
             during the study), iv) participate in at least six two-hour training sessions per week
             and played at least one match per week and v) non-smokers.

        Exclusion Criteria:

          -  i) a known milk intolerance or allergy, ii) a recent febrile illness, iii) history of
             muscle lesion, iv) lower limb trauma and v) metabolic diseases.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ATHANASIOS POULIOS, PhDc</last_name>
    <role>Principal Investigator</role>
    <affiliation>UNIVERSITY OF THESSALY, SCHOOL OF PHYSICAL EDUCATION &amp; SPORTS SCIENCES</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Exercise Biochemistry Laboratory, School of Physical Education &amp; Sports Sciences, University of Thessaly</name>
      <address>
        <city>Tr√≠kala</city>
        <zip>42100</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2017</study_first_submitted>
  <study_first_submitted_qc>November 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2017</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Thessaly</investigator_affiliation>
    <investigator_full_name>Athanasios Z. Jamurtas</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Myositis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

